COVID-19 Archive — Page 8 of 35

Stylized human figure surrounded by colorful enlarged representations of bacteria and other microorganisms, illustrating the human microbiome.
March 14, 2022

Microbiome reflects COVID-19 severity

Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered.

Illustration of red and pink Y-shaped antibodies surrounding blue spiky virus particles against a dark blue background.
March 10, 2022

Technique hastens COVID-19 antibody discovery

Optimization of a technique developed at Vanderbilt University Medical Center enables rapid and efficient identification of neutralizing monoclonal antibodies against the virus that causes COVID-19.

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.
March 7, 2022

Teen shares his battle with MIS-C following COVID-19 infection

Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children’s Hospital at Vanderbilt who developed MIS-C following COVID-19 infection.

Crystal Wix, RN, foreground, and care partner Carolyn Forgac work with a patient in the COVID intensive care unit in September 2021.
March 3, 2022

COVID-19: two years of challenges, lessons, victories

Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee.

VUMC’s ECMO program has expanded to areas outside of the Cardiovascular Intensive Care Unit.
February 25, 2022

Study shows young, healthy adults died from COVID-19 due to ECMO shortage

Vanderbilt research found that nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues

Amya Elliott, 9, talks with Bonnie Pilon, RN, prior to receiving her COVID-19 vaccination at Monroe Carell Jr. Children’s Hospital at Vanderbilt. The hospital began mass vaccination for children ages 5-11 on Monday, Nov. 8.
February 24, 2022

MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis

A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C).